Rani Therapeutics Holdings (RANI) Price to Book (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted Price to Book of 2.96 for Q2 2026, down 20.9% on a QoQ basis from 3.75 in Q1 2026, and up 184.17% year-over-year from 1.04 in Q2 2025.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Price to Book (2021 - 2026) Analysis & Trends
Rani Therapeutics Holdings has reported Price to Book for 6 years, with the latest figure at 2.96 in Q2 2026.
- On a quarterly basis, Price to Book rose 184.17% year-over-year to 2.96 in Q2 2026; TTM through Jun 2026 was 2.96, a 184.17% increase from a year earlier, with the FY2025 full-year figure at 3.95, down 82.44% from the prior year.
- Price to Book was 2.96 for Q2 2026 at Rani Therapeutics Holdings, down from 3.75 in the prior quarter.
- The five-year high for Price to Book was 34.65 in Q2 2024, with the low at 13.55 in Q1 2025.
- Average Price to Book over 5 years is 6.52, with a median of 4.2 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Price to Book jumped 716.18% in 2024, then plunged 225.67% in 2025.
- Over 5 years, Price to Book stood at 3.94 in 2022, then surged by 66.13% to 6.54 in 2023, then soared by 244.03% to 22.51 in 2024, then plunged by 82.44% to 3.95 in 2025, then decreased by 25.03% to 2.96 in 2026.
- The last three Price to Book figures came in at 2.96 (Q2 2026), 3.75 (Q1 2026), and 3.95 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Rani Therapeutics Holdings | 157.97 Mn | 157.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 |
| Mar 31, 2026 | 3.75 |
| Dec 31, 2025 | 3.95 |
| Sep 30, 2025 | -3.00 |
| Jun 30, 2025 | -3.52 |
| Mar 31, 2025 | -13.55 |
| Dec 31, 2024 | 22.51 |
| Sep 30, 2024 | 20.17 |
| Jun 30, 2024 | 34.65 |
| Mar 31, 2024 | 10.79 |
| Dec 31, 2023 | 6.54 |
| Sep 30, 2023 | 3.12 |
| Jun 30, 2023 | 4.25 |
| Mar 31, 2023 | 4.15 |
| Dec 31, 2022 | 3.94 |
| Sep 30, 2022 | 5.46 |
| Jun 30, 2022 | 5.15 |
| Mar 31, 2022 | 6.00 |
| Dec 31, 2021 | 7.22 |
| Sep 30, 2021 | 6.63 |